Literature DB >> 31715159

Chronic Neovascular Central Serous Chorioretinopathy: A Stress/Rest Optical Coherence Tomography Angiography Study.

Marco Lupidi1, Daniela Fruttini2, Chiara Maria Eandi3, Massimo Nicolò4, Diogo Cabral5, Silvia Tito6, Carlo Cagini7, Felice Cardillo Piccolino8.   

Abstract

PURPOSE: To compare optical coherence tomography-angiography (OCT-A) performed during physical exercise (stress OCT-A) to the basal examination (rest OCT-A) in the imaging of choroidal neovascularization (CNV) in patients with chronic central serous chorioretinopathy (CSCR).
DESIGN: Prospective, cohort study.
METHODS: This multicenter study included 29 consecutive patients with chronic CSCR and flat irregular pigment epithelium detachments (FIPEDs). All patients underwent rest and stress OCT-A (i.e., hand-grip test [HGT]). Systemic hemodynamic data were recorded during the examinations. Rest and stress OCT-A in the en-face and cross-sectional views were qualitatively compared to establish the degree of evidence of flow signals due to CNVs. The en-face angiograms underwent additional automated quantitative analysis to assess the rate of change in neovascular parameters during the stress condition.
RESULTS: Blood pressure significantly increased during the HGT (P = 0.001). Considering both the en-face and the cross-sectional images, CNV was identified in 13 eyes with the rest OCT-A and in 22 eyes with the stress OCT-A (P = 0.001). Cross-sectional imaging was more sensitive than en-face imaging in detecting neovascular blood flow signals under both rest (P = 0.125) and stress (P = 0.001) conditions. The quantitative analysis showed a significantly greater neovascular area and fractal dimension on the stress OCT-A (P = 0.002).
CONCLUSIONS: Performing OCT-A during HGT enhances the sensitivity of the examination in detecting CNV in chronic CSCR. The increased neovascular perfusion following the induced increase of blood pressure is consistent with choroidal blood flow dysregulation in patients with CSCR and indicates new areas of discussion about CNV in this disease.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31715159     DOI: 10.1016/j.ajo.2019.10.033

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  Pachychoroid Neovasculopathy Disguising as Age-Related Macular Degeneration Treated by Spironolactone and Anti-VEGF Combination Therapy.

Authors:  Leonie F Keidel; Benedikt Schworm; Siegfried G Priglinger; Jakob Siedlecki
Journal:  Case Rep Ophthalmol       Date:  2021-04-09

Review 2.  Biomarkers for central serous chorioretinopathy.

Authors:  Gideon Nkrumah; Manuel Paez-Escamilla; Sumit Randhir Singh; Mohammed Abdul Rasheed; Dmitri Maltsev; Abhilash Guduru; Jay Chhablani
Journal:  Ther Adv Ophthalmol       Date:  2020-08-24

3.  THE INCIDENCE OF NEOVASCULARIZATION IN CENTRAL SEROUS CHORIORETINOPATHY BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.

Authors:  M Cristina Savastano; Marco Rispoli; Bruno Lumbroso
Journal:  Retina       Date:  2021-02-01       Impact factor: 3.975

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.